Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. - Wikidata - awgldk - TriplyDB

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

http://www.wikidata.org/entity/Q42985641

about

Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysis Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?Neutrophil to lymphocyte ratio predicts persistent organ failure and in-hospital mortality in an Asian Chinese population of acute pancreatitis.Predictive Value of Preoperative Neutrophil Lymphocyte Ratio in Determining the Stage of Gastric Tumor.Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study.Immunity and immune suppression in human ovarian cancer.The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients Neutrophil count is associated with survival in localized prostate cancer Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.Advances in biomarker research for pancreatic cancer.The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram.The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib.Inflammation in malignant mesothelioma - friend or foe?Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy The neutrophil-to-lymphocyte ratio: a narrative review Neutrophils: important contributors to tumor progression and metastasis.Prognostic significance of neutrophil-lymphocyte ratios in large cell neuroendocrine carcinoma.Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma.The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.Incorporation of NLR into NIH stratification system increases predictive accuracy for surgically resected gastrointestinal stromal tumors.

P2860

Q24568136-0D2AC66F-7F30-4BDF-B787-4E6ECA7BDB4A Q26773406-5480F0F0-6D98-4B03-A3E3-8783A15FA4C2 Q27009534-E7A60D13-AB74-47F0-8810-2D30BB5BDA74 Q27022482-272A329A-E0B3-4D35-BBB5-8AF92E856606 Q28077206-BC174E23-DA55-4817-A84A-1D9DB5E4FA1B Q28083684-C83EDD32-6D7B-4CF3-9611-FF541CE0F5C0 Q28241308-4D5995AC-56E5-4076-9271-5922EE536805 Q33357295-EF7D691B-555D-4710-81B1-DDEB82137EFA Q33595219-85342088-E000-4D1B-834F-0499B7A8A664 Q33627306-0E10E20B-E7D8-4096-8470-098AD3118468 Q33762053-B55563A7-39CA-4213-B865-DA2D3E7848C9 Q35131890-7BCDDF9F-A96C-49B9-9FC8-B8E701FB8E39 Q35138135-DD3E6816-2394-4945-8EEF-CA55756B9B85 Q35274955-21004FAF-4029-48A7-AAFA-9E4CF091CEFF Q35424504-F176AC8D-F2C7-4A89-A28B-969A7DDA71BC Q35595696-772C8186-CC2C-4ADD-B3E5-5A0E493434C3 Q35751637-2CE60CB4-8EC4-4F4E-B09C-0F6E2BA54B6A Q35870682-F75281E3-3FFB-4209-B6FE-7C52E79EAFB5 Q35905137-ADB06897-AE70-4B0C-99E8-774800520214 Q35905788-17E4EFE9-2477-4952-B897-357D37F82946 Q36126609-1938C683-5828-4398-BCE3-29BDA3AF6C5B Q36353298-ADDD1964-F612-4C3B-85C7-32D242646B91 Q36464626-FDA1B398-FA5D-442C-9E00-BB6300154C6E Q36483161-A28C297F-92BB-43E3-84AB-F3B998FA6914 Q36569129-648C17DB-F24A-4769-A3D7-3E8F39860E7B Q36824972-BEE01283-9A76-49A3-BF42-97F21A380BAC Q37031596-BA365C8D-1576-409A-86F7-3C027DC67640 Q37089422-8FBD3B18-38D4-4E29-B836-241F5236A60E Q37090789-A85DF5B2-714D-4FDD-A31E-1E636B3757B8 Q37214300-8C7A4057-B693-4A83-997D-92BF20D87AAF Q37223578-64D320FD-20DE-4DFD-BE2E-D6F6BACCFE02 Q37295840-9E1E1BE9-C2AA-43BE-879B-DF3E5DB71407 Q37573454-9E9D4AAF-7A1D-414A-84DD-C9BE69331774 Q38585102-852D79C9-8F8C-4BE0-8F49-F6F8CF4E3109 Q38647526-17C04AB1-D502-45E4-B045-F23540133312 Q38735885-F8FB1D57-3A3D-4E92-AE50-DA6254420816 Q38806901-21F1B739-56F7-4241-838C-87FD2A2F7F4A Q38980174-1EDD2405-D9D1-470F-AEE8-5075DAA2BFFA Q39041165-4041E874-FA6B-4DA7-A159-42D9EFD2FD34 Q39049191-3B3A9426-CFB2-4F72-B9FB-75DDE2DF69CA

P2860

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

http://www.wikidata.org/entity/Q42985641

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

@en

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

@nl

type

label

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

@en

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

@nl

prefLabel

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

@en

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

@nl

P1433

Q42985641-71DBA890-B070-4022-A773-054EB70A2663

P1476

Q42985641-E6CE90A8-80AA-4C54-9708-6A436E02281E

P2093

Q42985641-106FF5D1-DE45-4534-B703-B7B404988A12

Q42985641-6DAF6D44-2200-4403-91A4-D78AB3B19D34

Q42985641-76FB5777-B7E7-4D45-85AB-18B75A88F864

Q42985641-AE08AAC8-167F-42A7-A688-7A0ACA67BBE6

Q42985641-BCC42931-C35C-4179-A51A-94A5E32FBFF3

Q42985641-BDCB677A-E11E-4BCC-8BBF-8DD4A933ACC1

Q42985641-DED21F9D-5F03-431D-9A85-70D0EA34D0F5

Q42985641-E2CEF956-2A76-478E-ADBC-BD7789E37434

Q42985641-E990F8E4-58A9-457C-B6B1-19C00E80C022

P2860

Q42985641-251AD7F2-7626-4C4B-9613-9EE60172D2B0

Q42985641-3C1720DF-0EB7-49A9-87C2-DF1826A5AC1B

Q42985641-3D135A51-72CB-42B3-9750-E111ED8BD406

Q42985641-3EEBCED1-8D07-489C-B71E-941806E8D326

Q42985641-410D1F21-6138-471A-9BA5-C2D3F474F455

Q42985641-5468B320-F2D6-4CEE-AC3D-6EBF1FEFB159

Q42985641-61259459-1775-4D2A-826D-10EB04894223

Q42985641-68B4C15B-E951-4B49-B198-C3F0863A014C

Q42985641-6DADACA0-59FE-48DB-92BD-B79BB0194FA5

Q42985641-74B5E6E5-027E-4B8A-914D-2974C0B77FD1

P304

Q42985641-5C985FCA-8D75-4917-ABE5-990909BB9CCB

P31

Q42985641-68870585-1C44-411A-9D83-55DAC585FB43

P356

Q42985641-5BD6272C-3BE3-45C1-BDA0-E5C645D0DF7F

P433

Q42985641-CE61C1F8-C82B-4DE2-BBA6-9A314108DC14

P478

Q42985641-861CC45B-73DA-4B3A-B5B4-197E2CF2E4A0

P577

Q42985641-D4CC5DE8-1D8D-4345-AAF1-E29AFC300D19

P698

Q42985641-07A39E3C-F351-4919-BBB5-5FD2F7D368CB

P356

1354750X.2010.491557

P1433

P1476

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

@en

P2093

Feng-Hua Wang

http://www.w3.org/2001/XMLSchema#string

Pei-Rong Ding

http://www.w3.org/2001/XMLSchema#string

Rui-Hua Xu

http://www.w3.org/2001/XMLSchema#string

Wen-Qi Jiang

http://www.w3.org/2001/XMLSchema#string

Xin An

http://www.w3.org/2001/XMLSchema#string

Yan-Xia Shi

http://www.w3.org/2001/XMLSchema#string

You-Jian He

http://www.w3.org/2001/XMLSchema#string

Yu-Hong Li

http://www.w3.org/2001/XMLSchema#string

Zhi-Qiang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer: back to Virchow?

Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.

Cancer of pancreas.

Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

Metastatic pancreatic cancer 2008: is the glass less empty?

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer.

Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor.

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

P304

516-522

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1354750X.2010.491557

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20602543

http://www.w3.org/2001/XMLSchema#string